Business Context and Reporting Period
This Form 8-K is a current report filed by Ekso Bionics Holdings, Inc. on March 3, 2021. The filing addresses Item 5.02 regarding the departure of directors or officers, election of directors, appointment of officers, and compensatory arrangements of certain officers. The report details compensation decisions made by the Compensation Committee on March 3, 2021, relating to the fiscal year ended December 31, 2020, and new equity grants for 2021.
Key Financial Metrics
The filing does not provide consolidated financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on executive compensation figures:
- 2020 Non-Equity Bonus Payouts:
- Jack Peurach: $82,500 (40% of target achieved).
- John Glenn: $55,000 (40% of target achieved).
- Jason Jones: $30,800 (40% of target achieved).
- 2021 Equity Grants (RSUs and PSUs):
- Jack Peurach: 45,725 RSUs and 45,725 PSUs.
- Jack Glenn: 13,015 RSUs and 13,015 PSUs.
- Jason Jones: 12,270 RSUs and 12,270 PSUs.
Material Changes
The filing reports the approval of 2020 bonus payouts at 40% of the target level, indicating partial achievement of 2020 milestones. Additionally, the company implemented a new equity compensation structure for 2021, splitting awards 50/50 between time-based Restricted Stock Units (RSUs) and performance-based Restricted Stock Units (PSUs) tied to 2021 revenue targets.
Guidance, Outlook, and Risks
Performance Targets: The 2021 PSUs are contingent on the Company's annual operating plan revenue for the fiscal year ended December 31, 2021. Vesting is structured as follows:
- 90% of Revenue Target: 50% of PSUs vest.
- 100% of Revenue Target: 100% of PSUs vest.
- 120% of Revenue Target: 150% of PSUs vest.
- Linear Vesting: Applies between thresholds.
Change in Control: In the event of a change in control prior to the determination of 2021 revenue targets, outstanding PSUs will convert to time-based vesting (matching RSU terms) assuming the target threshold was met, unless the Compensation Committee elects a higher vesting level based on actual performance.
Reporting Timeline: Full compensation details for the fiscal year ended December 31, 2020, will be disclosed in the proxy statement expected by April 30, 2021.
Investor Verification Checklist
- Verify the specific 2021 revenue targets approved by the Board, as these determine the value of the PSU grants.
- Review the upcoming proxy statement (due April 30, 2021) for the complete Summary Compensation Table for 2020.
- Monitor future filings for the actual 2021 revenue results to determine PSU vesting outcomes.
- Confirm the continued service status of the Named Executive Officers (NEOs) to ensure vesting conditions are met.